Posted 24 July 2024

Note regarding launch of new Nicovape® Q device and cartridges

In late June 2024, Liber launched the new Nicovape® Q system, the A2 model – more broadly referred to in the market as the Q2.

The new Nicovape® Q system (the Q2) has an increased capacity cartridge and more advanced electronic controls compared to the original (A1) system. As such, the device and cartridges of the Q2 Nicovape® Q system are not compatible with the original A1 Nicovape® Q system and vice versa.

The A1 Nicovape® Q system was removed from GP prescribing software at the end of June, therefore no new prescriptions for the A1 will be issued.

Patients currently using the A1 device may continue to be dispensed compatible A1 cartridges while they remain in stock, however, all new patients will be prescribed, and should be dispensed, the new Q2 Nicovape® Q system.

Note for Prescribers:

Please encourage your patients to contact Liber’s Customer Support team at support@liber.com.au prior to having their prescription dispensed to be directed to their nearest pharmacy holding stock of the new Q2 system.

Note for Pharmacists:

For reference in the dispensary:

• The Q2 device is readily recognisable by the ‘NFC Enabled’ logo on the lower right-hand front side of the device packaging. The A1 device does not have this.
• A1 cartridges are 1.5mL capacity in 59 mg/mL, 35 mg/mL and 20 mg/mL concentrations.
• Q2 cartridges are 2.0mL capacity labelled as Q50, Q35 and Q20 reflecting the respective concentrations.

The Q2 Nicovape® Q system is currently available from your preferred CSO wholesaler. If you experience any issues ordering Q2 products please contact support@liber.com.au for assistance.

Existing stock of the original A1 Nicovape® Q system should be retained to support patients with a current prescription for that product.

Details regarding the uplift of any remaining A1 stock will be communicated in early October 2024.